Bimzelx (bimekizumab-bkzx) — Point32Health
Hidradenitis suppurativa
Preferred products
- Humira
Initial criteria
- Documented diagnosis of hidradenitis suppurativa
- Patient age ≥ 18 years
- Prescribed by or in consultation with a dermatologist
- Documentation of one (1) of the following: a. Both of the following: i. Inadequate response to at least three (3) of the following conventional treatments: local hygiene and ordinary hygiene; weight reduction in patients who are obese; use of ordinary soaps and antiseptic and antiperspirant agents (e.g., aluminum chloride hexahydrate); application of warm compresses with sodium chloride solution or Burow’s solution; laser hair removal; cessation of cigarette smoking; medical anti-inflammatory or antiandrogen therapy such as oral or topical antibiotics, intralesional triamcinolone, spironolactone, or finasteride AND ii. Trial and failure with or contraindication to Humira OR b. The patient is new to the plan and stable on Bimzelx and the prescribing physician has documented that changing to a preferred product would result in adverse clinical outcomes